Fox FOXF Crushes Q1 2026 Estimates EPS 018 Tops Views Alaska Air ALK Q1 2026 Results Miss Estimates EPS 168 vs 136 USIran Tensions Flare as Ceasefire Nears Expiry Peace Talks Stalled ATN Intl ATNI Q1 2026 Disappoints EPS 029 Below 012 Views US Official Flags Japan as Part of FentanylSmuggling Route Global Worker Confidence Plunges Amid Rising AI Displacement Fears Kotak Mahindra Bank Shares Recent Market Performance and Investor Sentiment Cheniere Reports Strong Q1 2026 Results Raises FullYear Guidance Walmart Eyes Price Cuts With Tariff Refunds as Consumer Caution Grows Roth Capital Raises Target Price Target but Warns Q1 May Have Been a Goldilocks Quarter PSQH Q1 2026 Earnings Narrowed Loss Exceeds Analyst Estimates ABUS Q1 2026 Earnings Wider Loss Than Expected as Biotech Reports No Revenue AlTi Global Q1 2026 Earnings EPS Surges Past Estimates by 3072 Stock Drops 462 Redwood Trust Inc 900 Senior Notes Due 2029 RWTO Q1 2026 Earnings BottomLine Miss Underscores NearTerm Headwinds FibroBiologics FBLG Q1 2026 Earnings Narrow EPS Miss as PreRevenue Biotech Continues RD Investment Enterprise Products Partners EPD Slips 278 Key Support and Resistance Levels in Focus Mexico Fund Inc MXF Surges 175 Above Support Testing Key Resistance at 2318 Harmony Biosciences HRMY Edges Higher Testing Key Resistance Levels Tootsie Roll Industries TR Holds Steady Near Support as Volume Remains Subdued Oak Woods Acquisition Corp OAKU Holds Steady at 1220 as SPAC Sector Waits for Catalyst GEN Restaurant Group GENK Slips 234 as Shares Test Key Support Levels Eagle Point Credit Notes ECCW Steady Near Par as FixedIncome Market Consolidates Ocean Power Technologies OPTT Slides Slightly as Stock Hovers Near Key Support Buda Juice Inc BUDA Holds Steady at 876 as Support and Resistance Bounds Tighten Celldex Therapeutics CLDX Edges Lower Amid Consolidation Near Key Support Europes Satellite Vulnerability Telecom CEO Warns of US Dominance in AI and Space WCN Q1 2026 Earnings EPS Surpasses Estimates Amidst Modest Stock Decline Western Union WU Q1 2026 Earnings EPS Misses Estimates by a Wide Margin Shares Slide BioXcel Therapeutics BTAI Q1 2026 Earnings EPS Misses Expectations as PreRevenue Biotech Focuses on Pipeline Progress ORGO Q1 2026 Earnings EPS Falls Short of Estimates Amid Operational Challenges bioAffinity Technologies BIAF Q3 2025 Earnings Significant EPS Miss as Revenue Remains Zero Stock Declines 37 CNP Q1 2026 Earnings EPS Misses Estimate by a Narrow Margin Stock Edges Higher MMYT Q1 2026 Earnings EPS Misses Estimates but Stock Gains on Optimistic Travel Demand Outlook FBIN Q1 2026 Earnings Slight EPS Miss as Housing Headwinds Persist Shares Edge Higher